Search

Your search keyword '"Peters Oliver"' showing total 1,982 results

Search Constraints

Start Over You searched for: Author "Peters Oliver" Remove constraint Author: "Peters Oliver"
1,982 results on '"Peters Oliver"'

Search Results

1. Performance evaluation of automated white matter hyperintensity segmentation algorithms in a multicenter cohort on cognitive impairment and dementia

2. GFAP and NfL as fluid biomarkers for clinical disease severity and disease progression in multiple system atrophy (MSA)

3. Aggregation-resistant alpha-synuclein tetramers are reduced in the blood of Parkinson’s patients

4. Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS

5. The comorbidity profiles and medication issues of patients with multiple system atrophy: a systematic cross-sectional analysis

7. Different inflammatory signatures based on CSF biomarkers relate to preserved or diminished brain structure and cognition

8. Fronto-striatal alterations correlate with apathy severity in behavioral variant frontotemporal dementia

9. The comorbidity and co-medication profile of patients with progressive supranuclear palsy

15. A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer’s disease

16. Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer’s disease: results from the DELCODE study

17. Arterial hypertension and β-amyloid accumulation have spatially overlapping effects on posterior white matter hyperintensity volume: a cross-sectional study

18. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

19. Exploring the ATN classification system using brain morphology

20. Brain reserve contributes to distinguishing preclinical Alzheimer’s stages 1 and 2

21. Fornix fractional anisotropy mediates the association between Mediterranean diet adherence and memory four years later in older adults without dementia

22. Improving 3D convolutional neural network comprehensibility via interactive visualization of relevance maps: Evaluation in Alzheimer's disease

23. Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

24. Linking early-life bilingualism and cognitive advantage in older adulthood

25. Lifelong experiences as a proxy of cognitive reserve moderate the association between connectivity and cognition in Alzheimer's disease

26. Single-value brain activity scores reflect both severity and risk across the Alzheimer’s continuum

27. Don’t forget about tau: the effects of ApoE4 genotype on Alzheimer’s disease cerebrospinal fluid biomarkers in subjects with mild cognitive impairment—data from the Dementia Competence Network

28. New insights into the genetic etiology of Alzheimer’s disease and related dementias

29. Machine Learning-Based Perivascular Space Volumetry in Alzheimer Disease.

30. Plasma amyloid beta X‐42/X‐40 ratio and cognitive decline in suspected early and preclinical Alzheimer's disease.

31. Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer’s disease

32. Prominent Non-Memory Deficits in Alzheimer’s Disease Are Associated with Faster Disease Progression

33. Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia

34. Cognitive subtypes of probable Alzheimer's disease robustly identified in four cohorts

35. Perceived Physical Health and Cognitive Behavioral Therapy vs Supportive Psychotherapy Outcomes in Adults With Late-Life Depression

36. Predictors of Nursing Home Placement in a Cohort of European People with Alzheimer’s Disease and Other Dementia Cases Enrolled in SCU-B or Non SCU-B Centers: The RECage Study

37. Aβ oligomers peak in early stages of Alzheimer's disease preceding tau pathology

38. Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial

41. The BDNFVal66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer’s disease

42. Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals.

43. Inferior Frontal Sulcal Hyperintensities on Brain MRI Are Associated with Amyloid Positivity beyond Age—Results from the Multicentre Observational DELCODE Study.

44. Short communication: Lifetime musical activity and resting-state functional connectivity in cognitive networks.

45. The Cerebrospinal Fluid Free-Glycans Hex 1 and HexNAc 1 Hex 1 Neu5Ac 1 as Potential Biomarkers of Alzheimer's Disease.

47. Perivascular spaces in the brain enlarge over time; A three‐year longitudinal study

48. The effect of short Aβ(1‐38) peptides on cognitive decline and conversion to AD dementia: longitudinal data using the DELCODE cohort

49. Investigating biological age as a predictor of symptom progression in Alzheimer’s disease

50. P‐tau217 is the earliest plasma marker of dementia of the Alzheimer’s type in older primary care patients

Catalog

Books, media, physical & digital resources